A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Desomorphine
Danoprevir
The metabolism of Pexidartinib can be decreased when combined with Danoprevir.
Desomorphine
Ribociclib
The metabolism of Pexidartinib can be decreased when combined with Ribociclib.
Desomorphine
Stiripentol
The metabolism of Pexidartinib can be decreased when combined with Stiripentol.
Desomorphine
Ditiocarb
The metabolism of Pexidartinib can be decreased when combined with Ditiocarb.
Desomorphine
Elvitegravir
The metabolism of Elvitegravir can be decreased when combined with Pexidartinib.
Desomorphine
Selpercatinib
Selpercatinib may increase the hepatotoxic activities of Pexidartinib.
Desomorphine
Diroximel fumarate
Diroximel fumarate may increase the hepatotoxic activities of Pexidartinib.
Desomorphine
Mipomersen
Mipomersen may increase the hepatotoxic activities of Pexidartinib.
Desomorphine
Maraviroc
Maraviroc may increase the hepatotoxic activities of Pexidartinib.
Desomorphine
Onasemnogene abeparvovec
Onasemnogene abeparvovec may increase the hepatotoxic activities of Pexidartinib.
Desomorphine
Givosiran
Givosiran may increase the hepatotoxic activities of Pexidartinib.
Desomorphine
Thyrotropin
The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Pexidartinib.
Desomorphine
Benzylthiouracil
The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Pexidartinib.
Desomorphine
Elcatonin
The therapeutic efficacy of Elcatonin can be decreased when used in combination with Pexidartinib.
Desomorphine
Methylthiouracil
The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Pexidartinib.
Desomorphine
3,5-diiodothyropropionic acid
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Pexidartinib.
Desomorphine
Protirelin
The therapeutic efficacy of Protirelin can be decreased when used in combination with Pexidartinib.
Desomorphine
Potassium perchlorate
The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Pexidartinib.
Desomorphine
Dibromotyrosine
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Pexidartinib.
Desomorphine
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Pexidartinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3